Aquestive Therapeutics, Inc.
AQST나스닥Pharmaceutical PreparationsUS미국
30일 공시 수
8건
최근 2026.10.23
90일 내부자 순매수
-3억 8,047만원
순매도
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 16건
- US미국임원·주요주주 소유중요도 낮음2026.10.234 · Statement of changes in beneficial ownership
Aquestive Therapeutics, Inc.AQST
Form 4 · 2026.10.23
- US미국주요사항·수시공시중요도 낮음2026.10.208-K · Current report (Items 5.03, 9.01)
Aquestive Therapeutics, Inc.AQST
8-K · 2026.10.20 05:04 KST
- US미국임원·주요주주 소유중요도 보통2026.10.164 · Statement of changes in beneficial ownership
Aquestive Therapeutics, Inc.AQST
Form 4 · 2026.10.16
- US미국임원·주요주주 소유중요도 낮음2026.10.163 · Initial statement of beneficial ownership
Aquestive Therapeutics, Inc.AQST
Form 3 · 2026.10.16
- US미국주요사항·수시공시중요도 낮음2026.10.158-K · Current report (Items 7.01, 9.01)
Aquestive Therapeutics, Inc.AQST
8-K · 2026.10.15 20:21 KST
- US미국주요사항·수시공시중요도 높음2026.10.148-K · Current report (Items 1.01, 9.01)
Aquestive Therapeutics, Inc.AQST
8-K · 2026.10.14 20:21 KST
- US미국대량보유(5%)중요도 보통2026.10.07SCHEDULE 13G · Beneficial ownership report (13G)
Aquestive Therapeutics, Inc.AQST
SCHEDULE 13G · 2026.10.07
- US미국대량보유(5%)중요도 낮음2026.10.07정정SCHEDULE 13G/A · Beneficial ownership report (13G)
Aquestive Therapeutics, Inc.AQST
SCHEDULE 13G/A · 2026.10.07
- US미국지배구조·주총중요도 보통2026.09.298-K · Current report (Items 5.02, 9.01)
Aquestive Therapeutics, Inc.AQST
8-K · 2026.09.29 20:22 KST
- US미국주요사항·수시공시중요도 낮음2026.09.258-K · Current report (Items 7.01, 9.01)
Aquestive Therapeutics, Inc.AQST
8-K · 2026.09.25 20:59 KST